Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.0%

6 terminated/withdrawn out of 67 trials

Success Rate

87.5%

+0.9% vs industry average

Late-Stage Pipeline

6%

4 trials in Phase 3/4

Results Transparency

29%

12 of 42 completed trials have results

Key Signals

8 recruiting12 with results6 terminated

Enrollment reporting

Analytics

N/A
35(87.5%)
Phase 3
2(5.0%)
Phase 4
2(5.0%)
Phase 2
1(2.5%)
40Total
N/A(35)
Phase 3(2)
Phase 4(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (67)

Showing 20 of 67 trials
NCT07513519Not ApplicableCompleted

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

Role: lead

NCT07585604Not ApplicableRecruiting

Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT)

Role: collaborator

NCT05741424Not ApplicableCompleted

Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU

Role: collaborator

NCT07432113Not ApplicableRecruiting

Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.

Role: collaborator

NCT06174649Not ApplicableCompleted

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial

Role: collaborator

NCT07491419Not ApplicableRecruiting

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

Role: collaborator

NCT06829719Not ApplicableRecruiting

TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

Role: collaborator

NCT07267624Not ApplicableNot Yet Recruiting

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)

Role: collaborator

NCT06713642Not ApplicableCompleted

SPOTFIRE Sore Throat (ST) Study

Role: collaborator

NCT05064462Completed

TTV Viral Load in Heart Transplant Recipients

Role: collaborator

NCT04434209Not ApplicableTerminated

A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)

Role: lead

NCT06449183Not ApplicableCompleted

VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI)

Role: lead

NCT07453914Not ApplicableNot Yet Recruiting

Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and Stewardship

Role: lead

NCT05425251Completed

BRAINI-2 Elderly Mild TBI European Study

Role: collaborator

NCT02638779Not ApplicableCompleted

REAnimation Low Immune Status Markers

Role: collaborator

NCT04392401Recruiting

COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study

Role: collaborator

NCT06271655Not ApplicableActive Not Recruiting

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)

Role: collaborator

NCT03659773Not ApplicableCompleted

Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients

Role: collaborator

NCT02668237Not ApplicableCompleted

Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP

Role: collaborator

NCT05280132Not ApplicableRecruiting

Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial

Role: collaborator